The U.S. healthcare discount plan market size was exhibited at USD 2.10 billion in 2024 and is projected to hit around USD 5.70 billion by 2034, growing at a CAGR of 10.5% during the forecast period 2025 to 2034.
Report Coverage | Details |
Market Size in 2025 | USD 2.32 Billion |
Market Size by 2034 | USD 5.70 Billion |
Growth Rate From 2025 to 2034 | CAGR of 10.5% |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Segments Covered | Service |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Key Companies Profiled | New Benefits, Ltd.; AmeriPlan; CARRINGTON International Corporation; Florida Health Solution Corp.; Avia Dental Plan; Inc.; Best Care Medical Plan, Inc.; True Dental Discounts; United Health Group; Sam's Club; Cigna; Freshbenies; Humana; Xpress Healthcare |
The strong presence of Discount Medical Plan Organizations (DMPOs) offering affordable discount plans for distinct services, such as health advocacy, vision care, virtual visits, chiropractic care, dental care, alternative medicines, and prescription drugs, in the U.S. is a key factor expected to boost the DMPOs familiarity among the U.S. patient population. The U.S. market has a wide array of highly discounted health programs packaged with multiple benefits, such as individual coverage & family coverage.
These programs offer higher discounts than traditional high monthly premium insurance plans. The above-mentioned factors accelerate the adoption of healthcare discount plans. Key market players are focusing on devising strategies to increase public-private partnerships, collaborations, & investments and expand business coverage to minimize medication costs and offer users affordable & accessible healthcare solutions. Furthermore, increasing collaborative efforts among care providers and healthcare payers & insurance providers to reduce costs & expenses and enhance patient experience & quality of care is significantly improving clinical outcomes and boosting the market growth.
However, the presence of affordable health insurance companies in the country offering multiple health service plans is hindering market growth. Some players, such as United Healthcare, Cigna, BlueCross, Kaiser Permanente, and BlueShield, offer affordable and better insurance than medical discount plans. Thus, the high adoption of cheap insurance coverage plans over conventional discount plans is expected to limit market growth. Despite a significant number of players, there is a greater need to reinstate a well-structured insurance market capable of providing healthcare coverage at reasonable prices to most individuals not covered by employer-sponsored insurance policies or not considered under public entitlement programs.
The growing healthcare costs are driving consumers to adopt health discount plans rapidly. Although healthcare bundled payments offer value for providers, payers, and patients, consumers are not capable of exploiting their full potential. However, a wide range of healthcare discount solutions are being actively developed in the private health sector to encourage demand for forward-looking health plans. Key market participants are focusing on devising innovative product & service offerings to expand their portfolio and serve the growing demand. These key players promote affordable medical treatment plans through their service portfolio. For instance, the Health Care Transformation Task Force-an association of key health payers and health providers including Anthem, Aetna, and state-level Blue Cross Blue Shield plans, Sentara Healthcare, and Geisinger - had around 50.0% of its payer and provider members’ payment arrangements done via APMs in 2017, which increased to nearly 75.0% by 2020. Similarly, United Healthcare in March 2019, through its California Health Care Investment Program, invested USD 19 million to develop multiple health centers in California, improve patient care experience, enhance clinical outcomes across California, and deliver care to underserved communities of Santa Clara, Solano, and Santa Barbara.
The growing demand for health/medical discount plans to curb rising costs is anticipated to propel market growth. According to Centers for Medicare & Medicaid Services (CMS) and National Health Expenditure Accounts (NHEA) estimates, the healthcare spending in the U.S. in 2020 is USD 4.1 trillion or USD 12,530 per individual, accounting for 19.7% of the country’s overall GDP, thus, making the U.S. healthcare industry one of the largest industries. A growing number of mergers & acquisitions, collaborations, partnerships, and joint ventures among industry players enhance the quality of care, offer affordable treatment options, and deliver patient satisfaction. For instance, in April 2020, Cigna & Express Scripts partnered with Buoy Health to provide screening tools for COVID-19 and help customers & members understand their risks regarding the pandemic. In December 2019, Humana acquired Enclara, and this acquisition helped Humana advance in its clinical management expertise by expanding and leveraging Enclara’s capabilities.
The COVID-19 pandemic had a significant impact on the U.S. healthcare discount plan industry. The COVID-19 pandemic caused disruptions across the healthcare industry and forced governments to impose lockdowns and travel restrictions to minimize the transmission of infection. Care facilities and institutes underwent major structural transformations, and medical procedures were prioritized. The pandemic has exposed a flaw in the current benefit plans. They do not provide affordable coverage for critical services, such as telehealth, prescription drugs, diagnostics, and medical care, associated with pandemic–related illnesses.
Some government and private healthcare providers are offering additional support & protective equipment to caregivers, expanding telehealth access, and increasing flexibility in Medicaid benefits, to address COVID-19 public health emergency. The immediate implementation of reforms in the Value-based Insurance Design (V-BID) model by the Centers for Medicare & Medicaid Services (CMS) ensures affordable and easy access to critical clinical services.
In terms of service, the others service segment dominated the market in 2024 with the largest revenue share of 19.6%. The others segment includes medical supplies, lab services, LASIK & ultrasound, diabetic supplies, laboratory tests, X-rays, MRI, CT scans, diagnostics, surgeries, urgent care, endoscopies, and mammography. Market players are devising discount plans coupled with additional benefits on these services, and the growing awareness about the same among consumers is driving the growth of the segment. For instance, New Benefits, Ltd. offers 10 to 80% off on various laboratory testing services and 40 to 50% off on LASIK surgery costs. On the other hand, the virtual visits segment is anticipated to register the fastest growth rate over the forecast years.
This is owing to the rising burden of chronic diseases, increasing healthcare costs & the growing need to reduce out-of-pocket expenses. The launch of new discount plans, increasing startup funding, and growing penetration of health insurance companies to market the discount plans offered by DMPOs, especially in the U.S., are among the factors estimated to boost market growth in the coming years.
The virtual visits segment is estimated to register the fastest-growing CAGR of 13.1% over the forecast period. Owing to the convenience that it provides, it is gaining more popularity in the U.S. healthcare discount plan industry. For instance, AmeriPlan offers a monthly package of USD 19.95 for telemedicine services, which include online consultation, recommendation, & prescription medication with 24/7 access to doctors on the phone or over video calls. Such services also help members save out-of-pocket expenditures and avoid long clinic or hospital waiting times. Market participants are partnering and collaborating to launch discount plans promoting quality treatment & care at low costs.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. healthcare discount plan market
By Service
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service outlook
2.3. Competitive Insights
Chapter 3. U.S. Healthcare Discount Plan Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Market opportunity analysis
3.4. U.S. Healthcare Discount Plan Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. U.S. Healthcare Discount Plan: Service Estimates & Trend Analysis
4.1. U.S. Healthcare Discount Plan Market: Key Takeaways
4.2. U.S. Healthcare Discount Plan Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Health Advocate
4.3.1. Health advocate market estimates and forecasts, 2021 to 2034 (USD Million)
4.4. Virtual Visits
4.4.1. Virtual visits market estimates and forecasts, 2021 to 2034 (USD Million)
4.5. Alternative Medicines
4.5.1. Alternative medicines market estimates and forecasts, 2021 to 2034 (USD Million)
4.6. Prescription Drugs
4.6.1. Prescription drugs market estimates and forecasts, 2021 to 2034 (USD Million)
4.7. Dental Care
4.7.1. Vaccine delivery market estimates and forecasts, 2021 to 2034 (USD Million)
4.8. Vision Care
4.8.1. Vision care market estimates and forecasts, 2021 to 2034 (USD Million)
4.9. Hearing Aids
4.9.1. Hearing aids market estimates and forecasts, 2021 to 2034 (USD Million)
4.10. Chiropractic Care
4.10.1. Chiropractic care market estimates and forecasts, 2021 to 2034 (USD Million)
4.11. Nurse Services
4.11.1. Nurse services market estimates and forecasts, 2021 to 2034 (USD Million)
4.12. Vitamins & Supplements
4.12.1. Vitamins & supplements market estimates and forecasts, 2021 to 2034 (USD Million)
4.13. Wellness Plans
4.13.1. Wellness plans market estimates and forecasts, 2021 to 2034 (USD Million)
4.14. Podiatry Plans
4.14.1. Podiatry plans market estimates and forecasts, 2021 to 2034 (USD Million)
4.15. Others
4.15.1. Others market estimates and forecasts, 2021 to 2034 (USD Million)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Market Participant Categorization
5.2.1. New Benefits, Ltd.
5.2.1.1. Company overview
5.2.1.2. Financial performance
5.2.1.3. Product benchmarking
5.2.1.4. Strategic initiatives
5.2.2. AmeriPlan
5.2.2.1. Company overview
5.2.2.2. Financial performance
5.2.2.3. Product benchmarking
5.2.2.4. Strategic initiatives
5.2.3. CARRINGTON International Corporation
5.2.3.1. Company overview
5.2.3.2. Financial performance
5.2.3.3. Product benchmarking
5.2.3.4. Strategic initiatives
5.2.4. Florida Health Solution Corp.
5.2.4.1. Company overview
5.2.4.2. Financial performance
5.2.4.3. Product benchmarking
5.2.4.4. Strategic initiatives
5.2.5. Avia Dental Plan, Inc
5.2.5.1. Company overview
5.2.5.2. Financial performance
5.2.5.3. Product benchmarking
5.2.5.4. Strategic initiatives
5.2.6. Best Care Medical Plan, Inc
5.2.6.1. Company overview
5.2.6.2. Financial performance
5.2.6.3. Product benchmarking
5.2.6.4. Strategic initiatives
5.2.7. True Dental Discounts
5.2.7.1. Company overview
5.2.7.2. Financial performance
5.2.7.3. Product benchmarking
5.2.7.4. Strategic initiatives
5.2.8. United Health Group;
5.2.8.1. Company overview
5.2.8.2. Financial performance
5.2.8.3. Product benchmarking
5.2.8.4. Strategic initiatives
5.2.9. Sam's Club
5.2.9.1. Company overview
5.2.9.2. Financial performance
5.2.9.3. Product benchmarking
5.2.9.4. Strategic initiatives
5.2.10. Freshbenies
5.2.10.1. Company overview
5.2.10.2. Financial performance
5.2.10.3. Product benchmarking
5.2.10.4. Strategic initiatives
5.2.11. Humana
5.2.11.1. Company overview
5.2.11.2. Financial performance
5.2.11.3. Product benchmarking
5.2.11.4. Strategic initiatives
5.2.12. Xpress Healthcare
5.2.12.1. Company overview
5.2.12.2. Financial performance
5.2.12.3. Product benchmarking
5.2.12.4. Strategic initiatives